Publisher Future Science Group (FSG) has announced its support of the AllTrials campaign.
The AllTrials campaign aims to improve transparency and reporting of clinical trials. These aims align with those of Future Science Group (FSG), which believes that every trial should be conducted in a transparent and reproducible manner, ensuring that all research, even where negative or inconclusive, is both trustworthy and available to inform medical decision-making.
FSG requires all authors to follow the latest CONSORT and GPP3 guidelines. It is requested that trials are registered in a publicly accessible, free registry that is electronically searchable, open to prospective registrants and managed by a not-for-profit organisation. Where trials are unregistered, FSG requires a clear statement and explanation to be included in the article.
Those interested in submitting a trial report to a journal published by Future Science Group may contact info@future-science-group.com.
Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
